ProShares Ultra NASDAQ Biotechnology
32 hedge funds and large institutions have $54.6M invested in ProShares Ultra NASDAQ Biotechnology in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 9 closing their positions.
Holders
32
Holders Change
-4
Holders Change %
-11.11%
% of All Funds
0.56%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
5
Increased
8
Reduced
6
Closed
9
Calls
$8.41M
Puts
$8.01M
Net Calls
+$398K
Net Calls Change
-$6.77M